Why don’t women peer review as often as men? Fewer invites and RSVPs, researchers say

Brooks Hanson
Jory Lerback. Image courtesy of the University of Utah

Women don’t peer review papers as often as men, even taking into account the skewed sex ratio in science – but why? In a new Comment in today’s Nature, Jory Lerback at the University of Utah and Brooks Hanson at the American Geophysical Union (AGU) confirmed the same trend in AGU journals, which they argue serve as a good proxy for STEM demographics in the U.S. What’s more, they found the gender discrepancies stemmed from women – of all levels of seniority — receiving fewer invitations to review (both from male and female authors). And when women get their invites, they say “no” more often. We spoke with Lerback and Hanson about what might underlie this trend, and how the scientific community should address it.

Retraction Watch: What made you decide to undertake this project?

Continue reading Why don’t women peer review as often as men? Fewer invites and RSVPs, researchers say

Dangerous chemo mistake retracted by journal after two years

An oncology journal has retracted a 2014 paper that contained a potentially fatal mistake.

Specifically, the paper suggested that a chemotherapy drug be injected intrathecally — i.e., in the spine. But according to the retraction notice, the medical literature has unequivocally shown that that form of treatment is “uniformly fatal.”

The retraction comes approximately 18 months after the journal published a letter to the editor alerting readers to the risky wording in the 2014 paper.

Here’s the notice, issued by Hematological Oncology:

Continue reading Dangerous chemo mistake retracted by journal after two years

Happy birthday, RW Daily. Have you signed up yet?

A year ago tomorrow, we announced that we were starting The RW Daily, an email that would summarize the previous day’s news and link to other relevant stories elsewhere — a sort of sneak peek at Weekend Reads.

In about six and a half years, we’ve published more than 3,600 posts; that’s a lot of science publishing news. For people who feel overloaded by individual email alerts every time a new post appears, a daily digest is a good option. Here’s today’s, if you want to take a look. If you haven’t already, click here to subscribe. Continue reading Happy birthday, RW Daily. Have you signed up yet?

Journal retracts paper due to image mismatch; one co-author alleges fraud

Researchers have retracted a biology paper that included an image mismatch — despite the fact that, as they claim, another image in the same paper confirms the original findings.

The authors say they plan to resubmit the paper with the corrected figure panel.

The second to last author — Carlo Croce, chair of the department of cancer biology and genetics at The Ohio State University — told us he believes there’s more to the retraction than what the notice says. Specifically, he said that the paper includes an image from a previous paper by the same authors, which he called “fraud.”

Here’s the latest retraction notice, published in Cell Death and Differentiation:

Continue reading Journal retracts paper due to image mismatch; one co-author alleges fraud

Surgery chair who blamed image issues on software logs three more retractions

A researcher who claimed image problems in a retracted paper were the result of a software glitch, and not intentional, has lost three more papers — all for image manipulation.

In two notices, the Journal of Biological Chemistry specifies that duplicated images were used to represent different experimental conditions; one notice simply says the paper was affected by image manipulation.

All of the notices specify the papers are being retracted by the publisher, the American Society for Biochemistry and Molecular Biology — which this month published a set of recommendations for preparing a paper, including how to avoid excessive manipulation.

The papers were published between 2002 and 2010, and all share the same last author (Paul Kuo, currently chair of surgery at Loyola Medicine) and first author (Hongtao Guo, at Duke).

Here’s the first notice:

Continue reading Surgery chair who blamed image issues on software logs three more retractions

“We made big mistakes:” Gastric paper pulled with unusual notice

Sometimes we come across a real head-scratcher.

That happened this week, when we saw a retraction notice for a 2015 paper on gastric cancer in the International Journal of Clinical and Experimental Medicine, which only says the authors “made big mistakes” and contains two fairly significant typos.

Although there’s no sign of a retraction on PubMed, the table of contents for the latest issue of the journal lists the retraction — but includes no hyperlink to the notice. The only way to see it is via a Web cached version. Here’s the text:

Continue reading “We made big mistakes:” Gastric paper pulled with unusual notice

“Boom, headshot!” Disputed video game paper retracted

After a years-long dispute over a 2012 paper which suggested there might be some effects of first-person shooter video games on players, the journal has retracted the paper.

The stated reason in the notice: Some outside researchers spotted irregularities in the data, and contacted the corresponding author’s institution, Ohio State University, in 2015. Since the original data were missing, Communication Research is retracting the paper, with the corresponding author’s okay.

But as our story last month about this years-long dispute reported, there is a bit more to it.  Continue reading “Boom, headshot!” Disputed video game paper retracted

A Harvard whistleblower was subjected to a forced mental exam. Here’s why.

Last March, a PhD student at Harvard filed a misconduct allegation against his mentor, a prominent stem cell researcher. Three months later, he was taken from his home by police in the middle of the night for a forced psychiatric evaluation.

How did this happen? Continue reading A Harvard whistleblower was subjected to a forced mental exam. Here’s why.

At last, cancer reproducibility project releases some results — and they’re mixed

Nearly five years ago, researchers suggested that the vast majority of preclinical cancer research wouldn’t hold up to follow-up experiments, delaying much needed treatments for patients. In a series of articles publishing tomorrow morning, eLife has released the results of the first five attempts to replicate experiments in cancer biology — and the results are decidedly mixed.

As our co-founders Adam Marcus and Ivan Oransky write in STAT, the overall take-home message was that two studies generated findings similar to the original, one did not replicate the original, and two others were inconclusive.

They quote Brian Nosek, a psychologist at the University of Virginia, in Charlottesville, who runs the Center for Open Science, who has been leading the replication effort in his own field:

Continue reading At last, cancer reproducibility project releases some results — and they’re mixed

How to spot a “citation cartel”

Iztok Fister Jr

Do you know the difference between a group of researchers in the same field who cite each other’s related work, and a group of authors who purposefully cite each other in order to boost their own profiles? It’s not easy to do, say researchers in a new article about so-called “Citation cartels.” In Frontiers in Physics, Matjaz Perc and two Iztok Fisters (Senior and Junior) from the University of Maribor in Slovenia present an algorithm to help identify groups of researchers citing each other for overly collegial reasons. (For more on the phenomenon, see a recent column in STAT by our co-founders.) We spoke with first author Iztok Fister Jr.

Retraction Watch: What exactly are “citation cartels”? How do they differ from groups of researchers in the same field who tend to cite each other because their research is related in some way, without any nefarious intent? Continue reading How to spot a “citation cartel”